Holen Sie sich die Stockscreener-App
101.99
4.67%
4.55
Handel nachbörslich:
101.33
-0.66
-0.65%
Billiontoone Inc Aktie (BLLN) Neueste Nachrichten
Transcript : BillionToOne, Inc., Q3 2025 Earnings Call, Dec 09, 2025 - marketscreener.com
These Bay Area companies are IPO contenders in 2026 - The Business Journals
BillionToOne, Inc.: Strong Financial Performance and Strategic Market Positioning Drive Buy Rating - TipRanks
BillionToOne, Inc. SEC 10-Q Report - TradingView
BillionToOne stock rating reiterated at Overweight by Piper Sandler - Investing.com South Africa
Jim Cramer Says BillionToOne Has a “Fantastic Story” Within the Diagnostics Space - MSN
BillionToOne price target lowered to $145 from $150 at JPMorgan - TipRanks
BillionToOne Swings To Profit In Q3; Sees Q4 Revenue Soaring Up To 100% - Nasdaq
BillionToOne’s Strong Growth Potential and Strategic Integration Drive Buy Rating - TipRanks
BTIG Reiterates 'Buy' Rating for BillionToOne (BLLN) with PT of $160 | BLLN Stock News - GuruFocus
BillionToOne, Inc.: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating - TipRanks
Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% By Investing.com - Investing.com Nigeria
Billiontoone Q3 2025 Earnings Call Transcript - MarketBeat
BillionToOne Q3 2025 presentation slides: Revenue soars 117% as profitability achieved - Investing.com Canada
Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% - Investing.com
Earnings call transcript: BillionToOne's strong Q3 2025 lifts stock 3.19% - Investing.com
BillionToOne appoints Genmab CFO Anthony Pagano to board - Investing.com
BillionToOne sees Q4 revenue $84M-$90M, consensus $80.14M - TipRanks
BillionToOne Appoints Anthony Pagano as Audit Chair - TipRanks
BillionToOne reports Q3 EPS 10c, consensus 16c - TipRanks
BillionToOne appoints Genmab CFO Anthony Pagano to board By Investing.com - Investing.com India
BillionToOne Appoints Anthony Pagano to Board and Audit Committee - TradingView
BillionToOne sees FY25 revenue $293M-$299M, consensus $288.61M - TipRanks
(BLLN) BillionToOne Expects Full Year 2025 Revenue Range $293M$299M, vs. FactSet Est of $288.6M - marketscreener.com
(BLLN) BillionToOne, Inc. Expects Q4 Revenue Range $84.0M$90.0M - marketscreener.com
Earnings Flash (BLLN) BillionToOne, Inc. Reports Q3 Revenue $83.5M, vs. FactSet Est of $82.9M - marketscreener.com
BillionToOne Reports Third Quarter 2025 Results - The Manila Times
BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair - PR Newswire
Is BillionToOne’s Triple Digit Share Price Justified After Recent Volatility and Growth Hopes? - Yahoo Finance
Reassessing BillionToOne (BLLN) Valuation After a Recent Share Price Rebound - Yahoo Finance
BillionToOne initiated with an Overweight at JPMorgan - MSN
BillionToOne2025 Funding Rounds & List of Investors - Tracxn
BillionToOne, Inc.: Target Price Consensus and Analysts Recommendations | BLLN | US0901681058 - marketscreener.com
BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests - MSN
Billiontoone, Inc. (NASDAQ:BLLN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
BillionToOne initiated with a Hold at Jefferies - MSN
BillionToOne initiated with an Overweight at Piper Sandler - MSN
BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 - The Manila Times
BillionToOne (NASDAQ: BLLN) schedules Q3 2025 results and call for Dec. 9, 2025 - Stock Titan
Billiontoone (NASDAQ:BLLN) Coverage Initiated by Analysts at JPMorgan Chase & Co. - Defense World
Piper Sandler initiates BillionToOne stock coverage with Overweight rating By Investing.com - Investing.com South Africa
BillionToOne stock initiated at Overweight by JPMorgan on diagnostic tech - Investing.com Canada
BTIG initiates BillionToOne stock with Buy rating on prenatal testing growth - Investing.com Nigeria
BTIG initiates BillionToOne stock with Buy rating on prenatal testing growth By Investing.com - Investing.com South Africa
BillionToOne stock initiated at Equal Weight by Wells Fargo with $110 target - Investing.com Australia
BillionToOne Analysts Praise Molecular Diagnostic Firm's IPO RallyBillionToOne (NASDAQ:BLLN) - Benzinga
BillionToOne initiated with an Equal Weight at Wells Fargo - MSN
BillionToOne wins bullish backing, but Jefferies and Wells Fargo urge caution - Investing.com Canada
BillionToOne Shares Fall After Jefferies Initiates Coverage at Hold - marketscreener.com
BillionToOne initiated with an Outperform at William Blair - TipRanks
This Joby Aviation Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Benzinga
Jefferies Initiates BillionToOne at Hold With $117 Price Target - marketscreener.com
Stifel Initiates BillionToOne at Buy With $145 Price Target - marketscreener.com
Piper Sandler Initiates BillionToOne at Overweight With $150 Price Target - marketscreener.com
JPMorgan Initiates BillionToOne at Overweight With $150 Price Target - marketscreener.com
Wells Fargo Initiates BillionToOne at Equalweight With $110 Price Target - marketscreener.com
William Blair Initiates BillionToOne at Outperform - MarketScreener
BTIG Initiates BillionToOne at Buy With $160 Price Target - marketscreener.com
BillionToOne’s Hot IPO Has Analysts Onboard Early - Finimize
1.15%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):